Auto - Manufacturers
Compare Stocks
2 / 10Stock Comparison
BLBD vs DORM
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Parts
BLBD vs DORM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Auto - Manufacturers | Auto - Parts |
| Market Cap | $2.25B | $3.71B |
| Revenue (TTM) | $1.49B | $2.15B |
| Net Income (TTM) | $133M | $190M |
| Gross Margin | 21.0% | 40.7% |
| Operating Margin | 11.9% | 15.6% |
| Forward P/E | 14.9x | 15.0x |
| Total Debt | $90M | $633M |
| Cash & Equiv. | $229M | $49M |
BLBD vs DORM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Blue Bird Corporati… (BLBD) | 100 | 494.9 | +394.9% |
| Dorman Products, In… (DORM) | 100 | 177.5 | +77.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BLBD vs DORM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BLBD carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 9.9%, EPS growth 22.8%, 3Y rev CAGR 22.7%
- 5.6% 10Y total return vs DORM's 129.0%
- PEG 0.23 vs DORM's 1.00
DORM is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 0.95
- Lower volatility, beta 0.95, Low D/E 42.9%, current ratio 3.09x
- Beta 0.95, current ratio 3.09x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.9% revenue growth vs DORM's 6.0% | |
| Value | Lower P/E (14.9x vs 15.0x), PEG 0.23 vs 1.00 | |
| Quality / Margins | 8.9% margin vs DORM's 8.8% | |
| Stability / Safety | Beta 0.95 vs BLBD's 1.12 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +90.8% vs DORM's -0.1% | |
| Efficiency (ROA) | 21.0% ROA vs DORM's 7.6%, ROIC 102.6% vs 13.9% |
BLBD vs DORM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BLBD vs DORM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — BLBD and DORM each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DORM and BLBD operate at a comparable scale, with $2.2B and $1.5B in trailing revenue. Profitability is closely matched — net margins range from 8.9% (BLBD) to 8.8% (DORM). On growth, DORM holds the edge at +4.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.5B | $2.2B |
| EBITDAEarnings before interest/tax | $185M | $377M |
| Net IncomeAfter-tax profit | $133M | $190M |
| Free Cash FlowCash after capex | $184M | $71M |
| Gross MarginGross profit ÷ Revenue | +21.0% | +40.7% |
| Operating MarginEBIT ÷ Revenue | +11.9% | +15.6% |
| Net MarginNet income ÷ Revenue | +8.9% | +8.8% |
| FCF MarginFCF ÷ Revenue | +12.3% | +3.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -1.7% | +4.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +13.9% | -23.5% |
Valuation Metrics
BLBD leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 18.3x trailing earnings, BLBD trades at a 2% valuation discount to DORM's 18.7x P/E. Adjusting for growth (PEG ratio), BLBD offers better value at 0.29x vs DORM's 1.25x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.2B | $3.7B |
| Enterprise ValueMkt cap + debt − cash | $2.1B | $4.3B |
| Trailing P/EPrice ÷ TTM EPS | 18.30x | 18.69x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.89x | 15.00x |
| PEG RatioP/E ÷ EPS growth rate | 0.29x | 1.25x |
| EV / EBITDAEnterprise value multiple | 11.54x | 10.38x |
| Price / SalesMarket cap ÷ Revenue | 1.52x | 1.74x |
| Price / BookPrice ÷ Book value/share | 9.14x | 2.58x |
| Price / FCFMarket cap ÷ FCF | 14.66x | 49.02x |
Profitability & Efficiency
BLBD leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
BLBD delivers a 50.8% return on equity — every $100 of shareholder capital generates $51 in annual profit, vs $13 for DORM. BLBD carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to DORM's 0.43x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +50.8% | +13.1% |
| ROA (TTM)Return on assets | +21.0% | +7.6% |
| ROICReturn on invested capital | +102.6% | +13.9% |
| ROCEReturn on capital employed | +49.4% | +18.5% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.35x | 0.43x |
| Net DebtTotal debt minus cash | -$139M | $584M |
| Cash & Equiv.Liquid assets | $229M | $49M |
| Total DebtShort + long-term debt | $90M | $633M |
| Interest CoverageEBIT ÷ Interest expense | 394.69x | 8.24x |
Total Returns (Dividends Reinvested)
BLBD leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BLBD five years ago would be worth $26,265 today (with dividends reinvested), compared to $11,983 for DORM. Over the past 12 months, BLBD leads with a +90.8% total return vs DORM's -0.1%. The 3-year compound annual growth rate (CAGR) favors BLBD at 53.2% vs DORM's 12.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +51.9% | +0.0% |
| 1-Year ReturnPast 12 months | +90.8% | -0.1% |
| 3-Year ReturnCumulative with dividends | +259.6% | +41.2% |
| 5-Year ReturnCumulative with dividends | +162.6% | +19.8% |
| 10-Year ReturnCumulative with dividends | +559.4% | +129.0% |
| CAGR (3Y)Annualised 3-year return | +53.2% | +12.2% |
Risk & Volatility
Evenly matched — BLBD and DORM each lead in 1 of 2 comparable metrics.
Risk & Volatility
DORM is the less volatile stock with a 0.95 beta — it tends to amplify market swings less than BLBD's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BLBD currently trades 87.1% from its 52-week high vs DORM's 74.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 0.95x |
| 52-Week HighHighest price in past year | $81.51 | $166.89 |
| 52-Week LowLowest price in past year | $36.01 | $98.44 |
| % of 52W HighCurrent price vs 52-week peak | +87.1% | +74.4% |
| RSI (14)Momentum oscillator 0–100 | 70.4 | 73.1 |
| Avg Volume (50D)Average daily shares traded | 357K | 264K |
Analyst Outlook
DORM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates BLBD as "Buy" and DORM as "Buy". Consensus price targets imply 12.8% upside for DORM (target: $140) vs 11.2% for BLBD (target: $79).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $79.00 | $140.00 |
| # AnalystsCovering analysts | 12 | 16 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.2% | +1.1% |
BLBD leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). DORM leads in 1 (Analyst Outlook). 2 tied.
BLBD vs DORM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BLBD or DORM a better buy right now?
For growth investors, Blue Bird Corporation (BLBD) is the stronger pick with 9.
9% revenue growth year-over-year, versus 6. 0% for Dorman Products, Inc. (DORM). Blue Bird Corporation (BLBD) offers the better valuation at 18. 3x trailing P/E (14. 9x forward), making it the more compelling value choice. Analysts rate Blue Bird Corporation (BLBD) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BLBD or DORM?
On trailing P/E, Blue Bird Corporation (BLBD) is the cheapest at 18.
3x versus Dorman Products, Inc. at 18. 7x. On forward P/E, Blue Bird Corporation is actually cheaper at 14. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Blue Bird Corporation wins at 0. 23x versus Dorman Products, Inc. 's 1. 00x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BLBD or DORM?
Over the past 5 years, Blue Bird Corporation (BLBD) delivered a total return of +162.
6%, compared to +19. 8% for Dorman Products, Inc. (DORM). Over 10 years, the gap is even starker: BLBD returned +559. 4% versus DORM's +129. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BLBD or DORM?
By beta (market sensitivity over 5 years), Dorman Products, Inc.
(DORM) is the lower-risk stock at 0. 95β versus Blue Bird Corporation's 1. 12β — meaning BLBD is approximately 18% more volatile than DORM relative to the S&P 500. On balance sheet safety, Blue Bird Corporation (BLBD) carries a lower debt/equity ratio of 35% versus 43% for Dorman Products, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BLBD or DORM?
By revenue growth (latest reported year), Blue Bird Corporation (BLBD) is pulling ahead at 9.
9% versus 6. 0% for Dorman Products, Inc. (DORM). On earnings-per-share growth, the picture is similar: Blue Bird Corporation grew EPS 22. 8% year-over-year, compared to 8. 1% for Dorman Products, Inc.. Over a 3-year CAGR, BLBD leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BLBD or DORM?
Dorman Products, Inc.
(DORM) is the more profitable company, earning 9. 6% net margin versus 8. 6% for Blue Bird Corporation — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DORM leads at 16. 8% versus 11. 3% for BLBD. At the gross margin level — before operating expenses — DORM leads at 41. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BLBD or DORM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Blue Bird Corporation (BLBD) is the more undervalued stock at a PEG of 0. 23x versus Dorman Products, Inc. 's 1. 00x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Blue Bird Corporation (BLBD) trades at 14. 9x forward P/E versus 15. 0x for Dorman Products, Inc. — 0. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DORM: 12. 8% to $140. 00.
08Which pays a better dividend — BLBD or DORM?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is BLBD or DORM better for a retirement portfolio?
For long-horizon retirement investors, Blue Bird Corporation (BLBD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
12), +559. 4% 10Y return). Both have compounded well over 10 years (BLBD: +559. 4%, DORM: +129. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BLBD and DORM?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.